Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
A Harrogate teenager who was seriously injured in the Manchester Arena terror attack has been visited by the Queen.
A Leeds Beckett student who was reported missing following the Manchester bomb blast died in the terror attack, police have confirmed.
Police have applied for extra security support for Radio 1's Big Weekend, which could mean armed officers patrolling the event in Hull.